S'abonner

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study - 20/02/14

Doi : 10.1016/j.amjmed.2013.10.027 
Ido Weinberg a, Philimon Gona b, c, Christopher J. O'Donnell a, b, d, Michael R. Jaff a, 1, , Joanne M. Murabito b, e, 1
a Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, Boston, Mass 
b National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Mass 
c Division of Biostatistics and Health Services Research, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass 
d NHLBI Division of Intramural Research, Bethesda, Md 
e Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Mass 

Requests for reprints should be addressed to Michael R. Jaff, DO, Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, 55 Fruit St., Warren 905, Boston, MA 02114.

Abstract

Background

An increased interarm systolic blood pressure difference is an easily determined physical examination finding. The relationship between interarm systolic blood pressure difference and risk of future cardiovascular disease is uncertain. We described the prevalence and risk factor correlates of interarm systolic blood pressure difference in the Framingham Heart Study (FHS) original and offspring cohorts and examined the association between interarm systolic blood pressure difference and incident cardiovascular disease and all-cause mortality.

Methods

An increased interarm systolic blood pressure difference was defined as ≥10 mm Hg using the average of initial and repeat blood pressure measurements obtained in both arms. Participants were followed through 2010 for incident cardiovascular disease events. Multivariable Cox proportional hazards regression analyses were performed to investigate the effect of interarm systolic blood pressure difference on incident cardiovascular disease.

Results

We examined 3390 (56.3% female) participants aged 40 years and older, free of cardiovascular disease at baseline, mean age of 61.1 years, who attended a FHS examination between 1991 and 1994 (original cohort) and from 1995 to 1998 (offspring cohort). The mean absolute interarm systolic blood pressure difference was 4.6 mm Hg (range 0-78). Increased interarm systolic blood pressure difference was present in 317 (9.4%) participants. The median follow-up time was 13.3 years, during which time 598 participants (17.6%) experienced a first cardiovascular event, including 83 (26.2%) participants with interarm systolic blood pressure difference ≥10 mm Hg. Compared with those with normal interarm systolic blood pressure difference, participants with an elevated interarm systolic blood pressure difference were older (63.0 years vs 60.9 years), had a greater prevalence of diabetes mellitus (13.3% vs 7.5%,), higher systolic blood pressure (136.3 mm Hg vs 129.3 mm Hg), and a higher total cholesterol level (212.1 mg/dL vs 206.5 mg/dL). Interarm systolic blood pressure difference was associated with a significantly increased hazard of incident cardiovascular events in the multivariable adjusted model (hazard ratio 1.38; 95% CI, 1.09-1.75). For each 1-SD-unit increase in absolute interarm systolic blood pressure difference, the hazard ratio for incident cardiovascular events was 1.07 (95% CI, 1.00-1.14) in the fully adjusted model. There was no such association with mortality (hazard ratio 1.02; 95% CI 0.76-1.38).

Conclusions

In this community-based cohort, an interarm systolic blood pressure difference is common and associated with a significant increased risk for future cardiovascular events, even when the absolute difference in arm systolic blood pressure is modest. These findings support research to expand clinical use of this simple measurement.

Le texte complet de cet article est disponible en PDF.

Keywords : Cardiovascular disease, Cardiovascular risk, Interarm blood pressure difference


Plan


 Funding: The Framingham Heart Study is supported by the National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study (contract N01-HC-25195). Analysis for this project was supported by the NHLBI Division of Intramural Research.
 Conflicts of Interest: JMM is a board member of Vascular Interventional Advances (VIVA) Physicians, a 501c3 nonprofit education and research organization; all other authors have no potential conflicts of interest to disclose.
 Authorship: All authors had access to the data; other author roles were as follows: IW, study design, literature search, data interpretation, writing; PG, study design, data analysis, writing; CJD, study design, data interpretation, editing; MRJ, study design, data interpretation, editing; JMM, study design, data interpretation, editing.


© 2014  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 127 - N° 3

P. 209-215 - mars 2014 Retour au numéro
Article précédent Article précédent
  • Too Much Exercise: Right Ventricular Outflow Tract Tachycardia
  • Venkataramanan Gangadharan, Dinesh Sharma, Vijay Ramu, Timir Paul
| Article suivant Article suivant
  • Electronic Health Record Use, Intensity of Hospital Care, and Patient Outcomes
  • Saul Blecker, Keith Goldfeld, Naeun Park, Daniel Shine, Jonathan S. Austrian, R. Scott Braithwaite, Martha J. Radford, Marc N. Gourevitch

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.